Sphingosine 1-phosphate receptor 1 (S1PR1) is crucial for lymphocyte trafficking and a target in inflammatory diseases. Here, authors discover KSI6666, a competitive S1PR1 antagonist that suppresses inflammation through pseudoirreversible inhibition.
- Yuya Maruyama
- Yusuke Ohsawa
- Taishin Akiyama